Tuesday, February 22, 2005 11:46:59 AM
"The research grant is aimed at supporting the discovery of innovative drug candidates for the treatment of chronic Pain and Parkinson's Disease."
Both pain and Parkinson's are huge million dollar markets for DNAP/Biofrontera...pain especially!
That's an additional $2.6 million US a year for Biofrontera...on top of DNAP's pending investment of $25 million US over the next few years. More than enough cash to bring exciting drug products to market.
Sounds like kids in a Disney park having enough money to do ALL the rides...lol!
Better yet...it sounds like dedicated research scientists getting the critical funding to explore and develop their dreams into reality...a confirmation of their important work that has the potential for humanity to lessen pain and disease.
The biggest question for any innovative "penny stock" is whether they have enough cash to survive while their "disruptive technology" becomes established with revenue-generating products...
Without a doubt...DNAP and Biofrontera are sitting cash pretty for the next few years, a very laudable position that should be encouraging for DNAP investors.
Thanks for your posts.
God Bless and take care,
Robert
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM